← All trials
NCT06515002
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 11, 2024
- Primary completion
- Sep 9, 2026
- Completion date
- Jan 6, 2027
- First posted
- Jul 23, 2024
- Last posted
- Nov 1, 2024
- Enrollment
- 36
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Boehringer IngelheimLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.